BBLG

Bone Biologics
BBLG

Overview Fund Activity

12 hedge funds and large institutions have $470K invested in Bone Biologics in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.

Holders
12
Holders Change
+9
Holders Change %
+300%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
1
Sabby Management
Florida
$259K
2
Walleye Capital
2
Walleye Capital
New York
$170K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$10.7K
4
Millennium Management
4
Millennium Management
New York
$10K
5
WAM
5
Warberg Asset Management
Illinois
$6.29K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SM
1
Sabby Management
Florida
$259K 1,237,205 +1,237,205 New
Walleye Capital
2
Walleye Capital
New York
$170K 830,245 +830,245 New
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$10.7K 52,541 +52,541 New
Millennium Management
4
Millennium Management
New York
$10K 47,074 +47,074 New
WAM
5
Warberg Asset Management
Illinois
$6.29K 30,000 +30,000 New
UBS Group
6
UBS Group
Switzerland
$3.21K 15,263 +15,263 New
VF
7
Virtu Financial
New York
$3K 15,291 +15,291 New
HF
8
HRT Financial
New York
$3K 17,260 +17,260 New
CAN
9
Cetera Advisor Networks
California
$2.2K 10,473 +10,473 New
TRCT
10
Tower Research Capital (TRC)
New York
$2K 8,311 +434 +6%
Wells Fargo
11
Wells Fargo
California
$10 47 +26 +124%
Morgan Stanley
12
Morgan Stanley
New York
$2 10 +10 New
Vanguard Group
13
Vanguard Group
Pennsylvania
– – -33,461 Closed
CFGS
14
Concourse Financial Group Securities
Alabama
– – – –